Andrew J Hall1,2,3, Nicholas D Clement1,2, Luke Farrow3,4, Alasdair M J MacLullich1,5, Graham F Dall6, Chloe E H Scott1,7, Paul J Jenkins2,8,9, Timothy O White1,2, Andrew D Duckworth1,2,7. 1. Edinburgh Orthopaedics, Royal Infirmary of Edinburgh, Edinburgh, UK. 2. Scottish Orthopaedic Research Trust into Trauma (SORT-IT), Edinburgh, UK. 3. Scottish Hip Fracture Audit (SHFA), NHS National Services Scotland, UK. 4. University of Aberdeen, Aberdeen, UK. 5. Geriatric Medicine, Usher Institute, University of Edinburgh, Edinburgh, UK. 6. Borders General Hospital, Melrose, UK. 7. Department of Orthopaedics and Trauma, University of Edinburgh, Edinburgh, UK. 8. Glasgow Royal Infirmary, Glasgow, UK. 9. Scottish Committee for Orthopaedics & Trauma, Edinburgh, UK.
Abstract
AIMS: The primary aim was to assess the independent influence of coronavirus disease (COVID-19) on 30-day mortality for patients with a hip fracture. The secondary aims were to determine whether: 1) there were clinical predictors of COVID-19 status; and 2) whether social lockdown influenced the incidence and epidemiology of hip fractures. METHODS: A national multicentre retrospective study was conducted of all patients presenting to six trauma centres or units with a hip fracture over a 46-day period (23 days pre- and 23 days post-lockdown). Patient demographics, type of residence, place of injury, presentation blood tests, Nottingham Hip Fracture Score, time to surgery, operation, American Society of Anesthesiologists (ASA) grade, anaesthetic, length of stay, COVID-19 status, and 30-day mortality were recorded. RESULTS: Of 317 patients with acute hip fracture, 27 (8.5%) had a positive COVID-19 test. Only seven (26%) had suggestive symptoms on admission. COVID-19-positive patients had a significantly lower 30-day survival compared to those without COVID-19 (64.5%, 95% confidence interval (CI) 45.7 to 83.3 vs 91.7%, 95% CI 88.2 to 94.8; p < 0.001). COVID-19 was independently associated with increased 30-day mortality risk adjusting for: 1) age, sex, type of residence (hazard ratio (HR) 2.93; p = 0.008); 2) Nottingham Hip Fracture Score (HR 3.52; p = 0.001); and 3) ASA (HR 3.45; p = 0.004). Presentation platelet count predicted subsequent COVID-19 status; a value of < 217 × 109/l was associated with 68% area under the curve (95% CI 58 to 77; p = 0.002) and a sensitivity and specificity of 63%. A similar number of patients presented with hip fracture in the 23 days pre-lockdown (n = 160) and 23 days post-lockdown (n = 157) with no significant (all p ≥ 0.130) difference in patient demographics, residence, place of injury, Nottingham Hip Fracture Score, time to surgery, ASA, or management. CONCLUSION: COVID-19 was independently associated with an increased 30-day mortality rate for patients with a hip fracture. Notably, most patients with hip fracture and COVID-19 lacked suggestive symptoms at presentation. Platelet count was an indicator of risk of COVID-19 infection. These findings have implications for the management of hip fractures, in particular the need for COVID-19 testing. Cite this article: Bone Joint J 2020;102-B(9):1219-1228.
AIMS: The primary aim was to assess the independent influence of coronavirus disease (COVID-19) on 30-day mortality for patients with a hip fracture. The secondary aims were to determine whether: 1) there were clinical predictors of COVID-19 status; and 2) whether social lockdown influenced the incidence and epidemiology of hip fractures. METHODS: A national multicentre retrospective study was conducted of all patients presenting to six trauma centres or units with a hip fracture over a 46-day period (23 days pre- and 23 days post-lockdown). Patient demographics, type of residence, place of injury, presentation blood tests, Nottingham Hip Fracture Score, time to surgery, operation, American Society of Anesthesiologists (ASA) grade, anaesthetic, length of stay, COVID-19 status, and 30-day mortality were recorded. RESULTS: Of 317 patients with acute hip fracture, 27 (8.5%) had a positive COVID-19 test. Only seven (26%) had suggestive symptoms on admission. COVID-19-positive patients had a significantly lower 30-day survival compared to those without COVID-19 (64.5%, 95% confidence interval (CI) 45.7 to 83.3 vs 91.7%, 95% CI 88.2 to 94.8; p < 0.001). COVID-19 was independently associated with increased 30-day mortality risk adjusting for: 1) age, sex, type of residence (hazard ratio (HR) 2.93; p = 0.008); 2) Nottingham Hip Fracture Score (HR 3.52; p = 0.001); and 3) ASA (HR 3.45; p = 0.004). Presentation platelet count predicted subsequent COVID-19 status; a value of < 217 × 109/l was associated with 68% area under the curve (95% CI 58 to 77; p = 0.002) and a sensitivity and specificity of 63%. A similar number of patients presented with hip fracture in the 23 days pre-lockdown (n = 160) and 23 days post-lockdown (n = 157) with no significant (all p ≥ 0.130) difference in patient demographics, residence, place of injury, Nottingham Hip Fracture Score, time to surgery, ASA, or management. CONCLUSION:COVID-19 was independently associated with an increased 30-day mortality rate for patients with a hip fracture. Notably, most patients with hip fracture and COVID-19 lacked suggestive symptoms at presentation. Platelet count was an indicator of risk of COVID-19infection. These findings have implications for the management of hip fractures, in particular the need for COVID-19 testing. Cite this article: Bone Joint J 2020;102-B(9):1219-1228.
Entities:
Keywords:
COVID-19; Coronavirus; Femoral neck fracture; Hip fracture; Mortality; Neck of femur fracture; Outcomes; Platelets; Predictors; SARS-CoV-2
Authors: Asad Helal; David Botros; Fahad Qureshi; Khalid Alhreish; Lincoln Dutcher; Jordan Teel; Jonathon Dawkins; James Rizkalla Journal: Proc (Bayl Univ Med Cent) Date: 2022-03-22
Authors: Andrew J Hall; Nick D Clement; Alasdair M J MacLullich; A Hamish R W Simpson; Tim O White; Andrew D Duckworth Journal: Bone Joint Res Date: 2022-06 Impact factor: 4.410
Authors: Andrew J Hall; Nick D Clement; Alasdair M J MacLullich; A H R W Simpson; Antony Johansen; Tim O White; Andrew D Duckworth Journal: Bone Joint Res Date: 2022-06 Impact factor: 4.410
Authors: Laura Ruzzini; Sergio De Salvatore; Daniela Lamberti; Pierluigi Maglione; Ilaria Piergentili; Francesca Crea; Chiara Ossella; Pier Francesco Costici Journal: Int J Environ Res Public Health Date: 2021-06-18 Impact factor: 3.390